TY  - JOUR
AU  - Elkind, Mitchell S V
AU  - Veltkamp, Roland
AU  - Montaner, Joan
AU  - Johnston, S Claiborne
AU  - Singhal, Aneesh B
AU  - Becker, Kyra
AU  - Lansberg, Maarten G
AU  - Tang, Weihua
AU  - Kasliwal, Rachna
AU  - Elkins, Jacob
PY  - 2020
DO  - 10.1212/WNL.0000000000010038
UR  - http://hdl.handle.net/10668/15837
T2  - Neurology
AB  - We evaluated the effect of 2 doses of natalizumab on functional outcomes in patients with acute ischemic stroke (AIS). In this double-blind phase 2b trial, patients with AIS aged 18-80 years with NIH Stroke Scale scores of 5-23 from 53 US and European...
LA  - en
KW  - Aged
KW  - Brain Ischemia
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Immunologic Factors
KW  - Male
KW  - Middle Aged
KW  - Natalizumab
KW  - Recovery of Function
KW  - Stroke
TI  - Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial.
TY  - research article
VL  - 95
ER  -